Roots Analysis identifies top 10 viral vector manufacturers

Market research firm Roots Analysis has identified and listed the ten most significant viral vector manufacturers worldwide. These companies are pivotal in the rapidly advancing field of cell and gene therapy, where viral vectors are utilized to deliver genetic material into target cells.

The development and manufacturing of cell and gene therapies have seen substantial momentum, with over 30 commercially available products and hundreds of ongoing clinical trials. The COVID-19 pandemic has further accelerated the progress of new clinical candidates. Viral vectors are also being employed in vaccine development against diseases like HIV, influenza, and malaria.

Industry players, including Lonza, Fujifilm Diosynth, and Thermo Fisher Scientific, are making significant investments to expand their production capacities in response to increasing demand. This growth is also supported by technological advancements such as modular facilities, single-use bioreactors, and automated cell processing systems.

According to Roots Analysis, the identified companies possess the capabilities to support gene and cell therapy programs from preclinical stages through to commercial production. Their services encompass a wide array of viral types and manufacturing processes.

Roots Analysis' top ten list includes Advanced BioScience Laboratories, AGC Biologics, Aldeveron, Catalent Biologics, Charles River Laboratories, Lonza, Novartis, Oxford Biomedica, Thermo Fisher Scientific, and VectorBuilder.